Abstract
Quorum sensing (QS) is a bacterial communication process that depends on the bacterial population density. Itinvolves small diffusible signaling molecules which activate the expression of myriad genes that control diverse array offunctions like bioluminescence, virulence, biofilm formation, sporulation, to name a few. Since QS is responsible for virulencein the clinically relevant bacteria, inhibition of QS appears to be a promising strategy to control these pathogenicbacteria. With indiscriminate use of antibiotics, there has been an alarming increase in the number of antibiotic resistantpathogens. Antibiotics are no longer the magic bullets they were once thought to be and therefore there is a need fordevelopment of new antibiotics and/or other novel strategies to combat the infections caused by multidrug resistant organisms.Quorum sensing inhibition or quorum quenching has been pursued as one of such novel strategies. While antibioticskill or slow down the growth of bacteria, quorum sensing inhibitors (QSIs) or quorum quenchers (QQs) attenuate bacterialvirulence. A large body of work on QS has been carried out in deadly pathogens like Pseudomonas aeruginosa,Staphylococcus aureus, Vibrio fischeri, V. harveyi, Escherichia coli and V. cholerae etc to unravel the mechanisms of QSas well as identify and study QSIs. This review describes various aspects of QS, QSI, different model systems to studythese phenomena and recent patents on various QSIs. It suggests QSIs as attractive alternatives for controlling human,animal and plant pathogens and their utility in agriculture and other industries.
Keywords:Biofilms, multidrug resistance, patents, Pseudomonas aeruginosa, quorum sensing, quorum sensing inhibitors,Staphylococcus aureus, Vibrio cholerae, Autoinducer type 1, QS systems
Recent Patents on Anti-Infective Drug Discovery
Title:Bacterial Quorum Sensing Inhibitors: Attractive Alternatives for Control of Infectious Pathogens Showing Multiple Drug Resistance
Volume: 8Issue: 1
Author(s):Ashima K. Bhardwaj, Kittappa Vinothkumar and Neha Rajpara
Affiliation:
Keywords:Biofilms, multidrug resistance, patents, Pseudomonas aeruginosa, quorum sensing, quorum sensing inhibitors,Staphylococcus aureus, Vibrio cholerae, Autoinducer type 1, QS systems
Abstract: Quorum sensing (QS) is a bacterial communication process that depends on the bacterial population density. Itinvolves small diffusible signaling molecules which activate the expression of myriad genes that control diverse array offunctions like bioluminescence, virulence, biofilm formation, sporulation, to name a few. Since QS is responsible for virulencein the clinically relevant bacteria, inhibition of QS appears to be a promising strategy to control these pathogenicbacteria. With indiscriminate use of antibiotics, there has been an alarming increase in the number of antibiotic resistantpathogens. Antibiotics are no longer the magic bullets they were once thought to be and therefore there is a need fordevelopment of new antibiotics and/or other novel strategies to combat the infections caused by multidrug resistant organisms.Quorum sensing inhibition or quorum quenching has been pursued as one of such novel strategies. While antibioticskill or slow down the growth of bacteria, quorum sensing inhibitors (QSIs) or quorum quenchers (QQs) attenuate bacterialvirulence. A large body of work on QS has been carried out in deadly pathogens like Pseudomonas aeruginosa,Staphylococcus aureus, Vibrio fischeri, V. harveyi, Escherichia coli and V. cholerae etc to unravel the mechanisms of QSas well as identify and study QSIs. This review describes various aspects of QS, QSI, different model systems to studythese phenomena and recent patents on various QSIs. It suggests QSIs as attractive alternatives for controlling human,animal and plant pathogens and their utility in agriculture and other industries.
Export Options
About this article
Cite this article as:
K. Bhardwaj Ashima, Vinothkumar Kittappa and Rajpara Neha, Bacterial Quorum Sensing Inhibitors: Attractive Alternatives for Control of Infectious Pathogens Showing Multiple Drug Resistance, Recent Patents on Anti-Infective Drug Discovery 2013; 8 (1) .https://dx.doi.org/10.2174/1574891X11308010012
DOI https://dx.doi.org/10.2174/1574891X11308010012 | Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher | Online ISSN 2212-4071 |
Related Articles
- ADAM17 as a Therapeutic Target in Multiple Diseases
Current Pharmaceutical DesignCorrelation between Diabetes Mellitus and Peri-implantitis: A SystematicReview
Endocrine, Metabolic & Immune Disorders - Drug Targets Histone Deacetylase Inhibitors In Inflammatory Disease
Current Topics in Medicinal ChemistryEpigenetic and Disease Targets by Polyphenols
Current Pharmaceutical Design Novel Approaches to the Treatment of Obesity and Type 2 Diabetes Mellitus: Bioactive Leptin-Related Synthetic Peptide Analogs
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)The Role of High-density Lipoprotein in Oral and Dental Diseases
Current Medicinal ChemistryCurrent Applications of Biopolymer-based Scaffolds and Nanofibers as Drug Delivery Systems
Current Pharmaceutical DesignDirect and Indirect Antimicrobial Activities of Neuropeptides and their Therapeutic Potential
Current Protein & Peptide ScienceTelomere Length Variations in Aging and Age-Related Diseases
Current Aging ScienceSafety Considerations in the Use of Ketorolac for Postoperative Pain
Current Drug SafetyThe Potential Effect of Carvedilol Against Osteoporosis in Ovariectomized Rats
Current Drug Therapy Matrix Metalloproteinase Inhibitors as Prospective Agents for the Prevention and Treatment of Cardiovascular and Neoplastic Diseases
Current Topics in Medicinal ChemistryNanofibers: New Insights for Drug Delivery and Tissue Engineering
Current Topics in Medicinal Chemistry Probiotics in Intestinal and Non-Intestinal Infectious Diseases – Clinical Evidence
Current Pharmaceutical Design Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease
Current Pharmaceutical Design Inflammation as a Therapeutic Target in Acute Ischemic Stroke Treatment
Current Topics in Medicinal ChemistryIs there an Association Between Periodontitis and Atherosclerosis in Adults? A Systematic Review
Current Vascular Pharmacology Molecular Genetics of Porphyromonas gingivalis: Gingipains and other Virulence Factors
Current Protein & Peptide Science Nanostructured Biomaterials for Regenerative Medicine
Current NanoscienceMaterial Couture for Wound Healing and Regeneration: an Overview
Current Pharmaceutical Design
[8]ページ先頭